These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16427150)

  • 1. Serum-free hybridoma culture: ethical, scientific and safety considerations.
    Even MS; Sandusky CB; Barnard ND
    Trends Biotechnol; 2006 Mar; 24(3):105-8. PubMed ID: 16427150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the glycosylation profile of a monoclonal antibody produced by hybridomas cultured in serum-supplemented, serum-free or chemically defined media.
    Serrato JA; Hernández V; Estrada-Mondaca S; Palomares LA; Ramírez OT
    Biotechnol Appl Biochem; 2007 Jun; 47(Pt 2):113-24. PubMed ID: 17250495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternatives to the use of fetal bovine serum: serum-free cell culture.
    Gstraunthaler G
    ALTEX; 2003; 20(4):275-81. PubMed ID: 14671707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybridoma cell growth and monoclonal antibody yield in serum-free media.
    Simonson L; Morton H; Reedy E
    Cytobios; 1994; 77(310):159-65. PubMed ID: 8020250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol (Basel); 2002; 111():233-57. PubMed ID: 12678248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic analysis of hybridoma cells viability under mechanical shear stress with and without serum protection.
    Legazpi L; Laca A; Díaz M
    Bioprocess Biosyst Eng; 2009 Oct; 32(6):717-22. PubMed ID: 19153770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety issues of animal products used in serum-free media.
    Merten OW
    Dev Biol Stand; 1999; 99():167-80. PubMed ID: 10404888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat islet culture in serum-free medium containing silk protein sericin.
    Morikawa M; Kimura T; Murakami M; Katayama K; Terada S; Yamaguchi A
    J Hepatobiliary Pancreat Surg; 2009; 16(2):223-8. PubMed ID: 19219397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal Bovine Serum (FBS): Past - Present - Future.
    van der Valk J; Bieback K; Buta C; Cochrane B; Dirks WG; Fu J; Hickman JJ; Hohensee C; Kolar R; Liebsch M; Pistollato F; Schulz M; Thieme D; Weber T; Wiest J; Winkler S; Gstraunthaler G
    ALTEX; 2018; 35(1):99-118. PubMed ID: 28800376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Production of Monoclonal Antibodies: Technical, Scientific and Ethical Considerations.
    Lindl T
    ALTEX; 1988; 5(1):16-32. PubMed ID: 11227053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development, benefits and disadvantages of serum-free media.
    Froud SJ
    Dev Biol Stand; 1999; 99():157-66. PubMed ID: 10404887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient laboratory-scale production of monoclonal antibodies using membrane-based high-density cell culture technology.
    Trebak M; Chong JM; Herlyn D; Speicher DW
    J Immunol Methods; 1999 Nov; 230(1-2):59-70. PubMed ID: 10594354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of silk protein sericin as mitogenic factor for better mammalian cell culture.
    Terada S; Sasaki M; Yanagihara K; Yamada H
    J Biosci Bioeng; 2005 Dec; 100(6):667-71. PubMed ID: 16473778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human corneal epithelial equivalents for ocular surface reconstruction in a complete serum-free culture system without unknown factors.
    Yokoo S; Yamagami S; Usui T; Amano S; Araie M
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2438-43. PubMed ID: 18515584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum-free cell culture: the serum-free media interactive online database.
    Brunner D; Frank J; Appl H; Schöffl H; Pfaller W; Gstraunthaler G
    ALTEX; 2010; 27(1):53-62. PubMed ID: 20390239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of standardized cell culture conditions for tumor cells with potential clinical application.
    Stadler G; Wieser M; Steindl F; Grillari J; Katinger H; Pfragner R; Voglauer R
    Cytotherapy; 2007; 9(5):488-98. PubMed ID: 17786610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acoustic cell filter: a proven cell retention technology for perfusion of animal cell cultures.
    Shirgaonkar IZ; Lanthier S; Kamen A
    Biotechnol Adv; 2004 Jul; 22(6):433-44. PubMed ID: 15135491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of cell culture media on the expansion efficiency and T-cell receptor Vbeta (TRBV) repertoire of in vitro expanded T cells using feeder cells.
    Block A; Rohde M; Erben U; Hammer M; Hummel M; Blunert K; Schultheiss HP; Volk HD; Noutsias M
    Med Sci Monit; 2008 May; 14(5):BR88-95. PubMed ID: 18443543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability and proliferation of L929, tumour and hybridoma cells in the culture media containing sericin protein as a supplement or serum substitute.
    Cao TT; Zhang YQ
    Appl Microbiol Biotechnol; 2015 Sep; 99(17):7219-28. PubMed ID: 25895088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.